Tower Research Capital LLC (Trc) Regencell Bioscience Holdings LTD Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$12.18 - $23.04 $1,035 - $1,958	85 New	85 $1,000
Q1 2023 May 09, 2023	BUY	$25.23 - $30.19 $5,046 - $6,038	200 New	200 $5,000
Q3 2022 Nov 10, 2022	SELL	$26.94 - $40.8 $5,549 - $8,404	-206 Reduced 35.64%	372 $12,000
Q2 2022 Aug 15, 2022	BUY	$20.67 - $45.78 $3,017 - $6,683	146 Added 33.8%	578 $20,000
Q1 2022 May 12, 2022	BUY	$21.4 - $40.0 $9,244 - $17,280	432 New	432 $10,000
Q4 2021 Feb 14, 2022	SELL	$13.43 - $32.87 $43,916 - $107,484	-3,270 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.3 - $46.33 $20,601 - $151,499	3,270 New	3,270 $74,000

18.1K

Ticker RGC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,012,900
Market Cap $66.6M
Description
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.